Two new studies have delivered a multitude of new markers linked to testicular cancer, as well as a better understanding of the genetic architecture of the disease.
New data points to strong predictive ability for a ddPCR-based test of AR copy number, while other companies are pursuing tests that target expression of AR splice variants.
The researchers plan to enroll 400 patients in the pilot, with the goal of increasing the availability of targeted therapies to pediatric cancer patients.
Researchers identified a germline variant on chromosome 6 that corresponded to overall survival times in multiple myeloma patients from four study cohorts.
Combining the new risk variants with those found in the past, researchers came up with a risk score that may eventually help find those most susceptible to the disease.
An Institute of Cancer Research-led team conducted a meta-analysis that uncovered five new variants linked to glioma development, including one that greatly increases risk of glioblastoma.
